Download PDF
Tierarztl Prax Ausg K Kleintiere Heimtiere 2012; 40(02): 113-121
DOI: 10.1055/s-0038-1623636
Übersichtsartikel
Schattauer GmbH

Einsatz von Fluorchinolonen bei bakteriellen Harnwegsinfektionen der Katze

The use of fluoroquinolones in bacterial urinary tract infections in cats
S. Kramer
1   Klinik für Kleintiere der Stiftung Tierärztliche Hochschule Hannover
,
M. Kietzmann
2   Institut für Pharmazie, Pharmakologie und Toxikologie2 der Stiftung Tierärztliche Hochschule Hannover
,
W.-R. Pankow
3   Vétoquinol GmbH, Ravensburg
› Author Affiliations
Further Information

Publication History

Eingegangen: 07 April 2011

Akzeptiert nach Revision: 06 October 2011

Publication Date:
06 January 2018 (online)

    Permissions and Reprints

Zusammenfassung

Ältere Katzen (> 10 Jahre) mit Symptomen der FLUTD (Feline Lower Urinary Tract Disease) sind häufig von Harnwegsinfektionen betroffen. Zusätzlich werden bei diesen Katzen meist Organerkrankungen (z. B. chronische Niereninsuffizienz, Diabetes mellitus) oder iatrogene Ursachen (Immunsuppressiva, Blasenverweilkatheter) festgestellt, die offensichtlich prädisponierend wirken. Aus diagnostischer Sicht zählen Harnanalyse und -kultur zu den wichtigsten Instrumenten, um eine Bakteriurie aufzudecken. Das mikrobiologische Spektrum bei der Katze wird dabei – ähnlich wie beim Hund – von Escherichia (E.) coli dominiert, aber auch Staphylococcus spp. und Enterococcus spp./Streptococcus spp. werden isoliert. Grundlage der antibiotischen Therapie sollten die Ergebnisse eines Antibiogramms sein. Steht diese Information nicht zur Verfügung, muss die Wirkstoffwahl bei unkomplizierten Harnwegsinfektionen auf empirischer Grundlage getroffen werden. Unter Berücksichtigung ihrer Verträglichkeit sind Antibiotika zu bevorzugen, die bei der Katze eine hohe renale Ausscheidung besitzen und somit therapeutisch wirksame Spiegel im Harn garantieren. Unter diesen Aspekten gehören die Fluorchinolone zum Spektrum der geeigneten Harnwegstherapeutika bei der Katze. Die therapeutische Relevanz von im Harn erreichbaren Wirkstoffspiegeln wird am Beispiel des Fluorchinolons Marbofloxacin, ein Fluorchinolon der 3. Generation, diskutiert. Neue pharmakokinetische Untersuchungen zur Substanz zeigen, dass im Urin von gesunden Katzen nach einmaliger Gabe von 2 bzw. 4 mg/kg KM s. c. Wirkstoffkonzentrationen von ≥ 2 μg/ml über 72 bzw. 103 Stunden aufrechterhalten werden.

Summary

Older cats (> 10 years) with FLUTD (Feline Lower Urinary Tract Disease) symptoms are often affected by urinary tract infections. In most of these cats organ diseases (e. g. chronic renal failure, diabetes mellitus) or iatrogenic factors (immunosuppressive drugs, indwelling catheter) are found that clearly predispose cats to this kind of infection. From a diagnostic point of view, urinalysis and urine culture are the most important tools in detecting bacteriuria. The microbiological spectrum is thereby comparable to that found in dogs, revealing Escherichia (E.) coli but also Staphylococcus spp. and Enterococcus spp./Streptococcus spp. Antibiotic therapy should be based on the results of susceptibility testing. If this kind of information is not available, drug selection has to be decided on an empirical basis unless it is a complicated urinary tract infection. Preferred antibiotics should have a high renal excretion rate and thus ensure therapeutically effective drug levels in the urine. In this respect, the fluoroquinolones belong to the group of appropriate drugs to be used in cats. The relevance of therapeutical drug concentrations achievable in the urine is discussed for the example of marbofloxacin, a third-generation fluoroquinolone. New pharmacokinetic data showed that marbofloxacin concentrations of ≥ 2 μg/ml are maintained in the urine of healthy cats for 72 and 103 hours after administration of 2 and 4 mg/kg BW s. c., respectively.

Schlüsselwörter

Bakterielle Harnwegsinfektion - Katze - Antibiotika - Pharmakokinetik - Fluorchinolone - Marbofloxacin

Key words

Urinary tract infection - cat - antibiotics - pharmacokinetics - fluoroquinolones - marbofloxacin
 

  • Literatur

  • 1 Albarellos GA, Montoya L, Landoni MF. Pharmacokinetics of marbofloxacin after single intravenous and repeat oral administration to cats. Vet J 2005; 170: 222-229.
    CrossrefPubMedGoogle Scholar
  • 2 Alvarez AI, Perez M, Prieto JG, Molina AJ, Real R, Merino G. Fluoroquinolone efflux mediated by ABC transporters. J Pharm Sci 2008; 97: 3483-3493.
    CrossrefPubMedGoogle Scholar
  • 3 Anonym Kinetics in cats (p28); Efficacy indicators (p43). Marbocyl® Reference Book; Vétoquinol SA, Lure (France): 1996
    Google Scholar
  • 4 Bailiff NL, Westropp JL, Nelson RW, Sykes JE, Owens SD, Kass PH. Evaluation of urine specific gravity and urine sediment as risk factors for urinary tract infections in cats. Vet Clin Pathol 2008; 37: 317-322.
    CrossrefPubMedGoogle Scholar
  • 5 Barber JP, Rawlings JM, Markwell PJ, Elliott J. Incidence and prevalence of bacterial urinary tract infections in cats with chronic renal failure. J Vet Int Med 1999; 13: 251.
    PubMedGoogle Scholar
  • 6 Barsanti JA. Genitourinary infections. In: Infectious Diseases of the Dog and Cat. Greene CE. ed. St. Louis (USA): Saunders Elsevier; 2006: 935-949.
    Google Scholar
  • 7 Barsanti JA. Multidrug-resistant urinary tract infection. In: Kirk’s Current Veterinary Therapy XIV. Bonagura JD, Twedt DC. eds. Philadelphia (USA): Saunders Elsevier; 2009: 921-925.
    Google Scholar
  • 8 Barsanti JA, Bartges JW. Bacterial urinary tract infection in cats. In: Kirk’s Current Veterinary Therapy XIII. Bonagura JD. ed. Philadelphia USA: Saunders Elsevier; 2000: 880-882.
    Google Scholar
  • 9 Bartges JW. Revisting bacterial urinary tract infection. In: Consultations in Feline Internal Medicine. Vol 5. August JR. ed. St. Louis: Elsevier; 2006: 441-446.
    Google Scholar
  • 10 Bartges JW. Diagnosis of urinary tract infections. Vet Clin Small Anim Pract 2004; 34: 923-933.
    CrossrefPubMedGoogle Scholar
  • 11 Blanco LJ, Bartges JW. Understanding and eradicating bacterial urinary tract infections. Vet Med 2001; 96: 776-789.
    PubMedGoogle Scholar
  • 12 Buffington CA, Chew DJ, Kendall MS, Scrivani PV, Thompson SB, Blaisdell JL, Woodworth BE. Clinical evaluation of cats with non obstructive urinary tract diseases. J Am Vet Med Assoc 1997; 210: 46-50.
    PubMedGoogle Scholar
  • 13 Cester CC, Schneider M, Toutain PL. Comparative kinetics of two orally administered fluoroquinolones in dog: Enrofloxacin versus marbofloxacin. Rev Med Vet 1996; 147: 703-716.
    PubMedGoogle Scholar
  • 14 Chen YM, Wright PJ, Lee CS, Browning GF. Uropathogenic virulence factors in isolates of Escherichia coli from clinical cases of canine pyometra and feces of healthy bitches. Vet Microbiol 2003; 94: 57-69.
    CrossrefPubMedGoogle Scholar
  • 15 Chew DJ, Dibartola SP, Schenck PA. Canine and Feline Nephrology and Urology. St. Louis (USA): Elsevier Saunders; 2011
    Google Scholar
  • 16 Daube G, Mensinger S, Stephan B. Pharmacokinetics – What you need to know. Proc. 4th International Baytril®; Symposium, Florence (Italy): 18-19. June, 2009. 74-79.
    Google Scholar
  • 17 Demuth D, Althaus FR. Pharmakotherapie. In: Krankheiten der Katze. Horzinek MC, Schmidt V, Lutz H. Hrsg. Stuttgart: Enke; 2003: 763-766.
    Google Scholar
  • 18 van Duijkeren E, van Laar P, Houwers DJ. Cystocentesis is essential for reliable diagnosis of urinary tract infections in cats. Tijdschr Diergeneeskd 2004; 129: 394-396.
    PubMedGoogle Scholar
  • 19 Dunning M, Stonehewer J. Urinary tract infections in small animals: pathophysiology and diagnosis. In Practice 2002; 24: 418-432.
    CrossrefPubMedGoogle Scholar
  • 20 Dunning M, Stonehewer J. Urinary tract infections in small animals: therapeutic options and management of problem cases. In Practice 2002; 24: 518-527.
    CrossrefPubMedGoogle Scholar
  • 21 Eggertsdóttir AV, Lund HS, Krontveit R, Sørum H. Bacteriuria in cats with feline lower urinary tract disease: a clinical study of 134 cases in Norway. J Feline Med Surg 2007; 09: 458-465.
    CrossrefPubMedGoogle Scholar
  • 22 Ford MM, Dubielzig RR, Giuliano EA, Moore CP, Narfström KL. Ocular and systemic manifestations after oral administration of a high dose of enrofloxacin in cats. Am J Vet Res 2007; 68: 190-202.
    CrossrefPubMedGoogle Scholar
  • 23 Frimodt-Møller N. Correlation between pharmacokinetic/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection. Int J Antimicrob Agents 2002; 19: 546-553.
    CrossrefPubMedGoogle Scholar
  • 24 Frimodt-Møller N, Maigaard S, Madsen PO. Effect of urine concentration versus tissue concentration of ampicillin and mecillinam on bacterial adherence in the rat bladder. Invest Urol 1981; 18: 322-325.
    PubMedGoogle Scholar
  • 25 Greene CE, Watson ADJ. Quinolones. In: Infectious Diseases of the Dog and Cat. Greene CE. ed. St. Louis (USA): Saunders Elsevier; 2006: 292-297.
    Google Scholar
  • 26 Griffin DW, Gregory CR. Prevalence of bacterial urinary tract infection after perineal urethrostomy in cats. J Am Vet Med Assoc 1992; 200: 681-684.
    PubMedGoogle Scholar
  • 27 Grobbel M, Lübke-Becker A, Alesik E, Schwarz S, Wallmann J, Werckenthin C, Wieler LH. Antimicrobial susceptibility of Escherichia coli from swine, horses, dogs and cats as determined in the BfT-GermVet monitoring program 2004–2006. Berl Münch Tierärztl Wschr 2007; 120: 391-401.
    PubMedGoogle Scholar
  • 28 Grobbel M, Lübke-Becker A, Alesik E, Schwarz S, Wallmann J, Werckenthin C, Wieler LH. Antimicrobial susceptibility of Klebsiella spp. and Proteus spp. from various organ systems in horses, dogs and cats as determined in the BfT-GermVet monitoring program 2004–2006. Berl Münch Tierärztl Wschr 2007; 120: 402-411.
    PubMedGoogle Scholar
  • 29 Guardabassi L, Houser GA, Frank LA, Papich MG. Guidelines for antimicrobial use in dogs and cats. Urinary tract infections (UTI). In: Guide to Antimicrobial Use in Animals. Guarddabassi L, Jensen LB, Kruse H. eds. Oxford: Blackwell; 2008: 193-196.
    Google Scholar
  • 30 Gyles CL, Fairbrother JM. Escherichia coli. In: Pathogenesis of Bacterial Infections in Animals. Gyles CL, Prescott JF, Songer JG, Thoen CO. eds. Ames, Iowa (USA): Blackwell; 2004: 193-223.
    Google Scholar
  • 31 Hesse A, Neiger R. Harnsteine bei Kleintieren. Stuttgart: Enke; 2008: 126-132.
    Google Scholar
  • 32 Hostutler RA, Chew DJ, DiBartola SP. Recent concepts in feline lower urinary tract disease. Vet Clin North Am Small Anim Pract 2005; 35: 147-170.
    CrossrefPubMedGoogle Scholar
  • 33 Ihrke PJ, Norton AL, Ling GV, Stannard AA. Urinary tract infection associated with long-term corticosteroid administration in dogs with chronic skin diseases. J Am Vet Med Assoc 1985; 186: 43-46.
    PubMedGoogle Scholar
  • 34 Kietzmann M, Niedorf F, Kramer S, Hoffmann M, Schneider M, Valle M, Pankow R. Plasma and urine concentrations of Marbofloxacin following single subcutaneous administration to cats. Berl Münch Tierärztl Wschr 2011; 124: 83-88.
    PubMedGoogle Scholar
  • 35 Kruger JM, Osborne CA, Goyal SM, Wickstrom SL, Johnston GR, Fletcher TF, Brown PA. Clinical evaluation of cats with lower urinary tract disease. J Am Vet Med Assoc 1991; 199: 211-216.
    PubMedGoogle Scholar
  • 36 Kruger JM, Conway TS, Kaneene JB, Perry RL, Hagenlocker E, Golombek A, Stuhler J. Randomized controlled trial of the efficacy of short-term amitriptyline administration for treatment of acute, non obstructive, idiopathic lower urinary tract disease in cats. J Am Vet Med Assoc 2003; 222: 749-758.
    CrossrefPubMedGoogle Scholar
  • 37 Kruth S. Urinary tract infections. In: Antimicrobial Therapy in Veterinary Medicine. Giguère S, Prescott JF, Baggot JD, Walker RD, Dowling PM. eds. Ames, Iowa, USA: Blackwell; 2006: 372-379.
    Google Scholar
  • 38 Kruth S. Gram-negative bacterial infections. In: Infectious Diseases of the Dog and Cat. Greene CE. ed. St. Louis (USA): Saunders Elsevier; 2006: 320-330.
    Google Scholar
  • 39 Labato MA. Uncomplicated urinary tract infection. In: Kirk’s Current Veterinary Therapy XIV. Bonagura JD, Twedt DC. eds. St. Louis (USA): Saunders Elsevier; 2009: 918-921.
    Google Scholar
  • 40 Lees GE, Osborne CA. Use and misuse of indwelling urethral catheters. Vet Clin North Am Small Anim Pract 1984; 14: 599-608.
    CrossrefPubMedGoogle Scholar
  • 41 Lekcharoensuk C, Osborne CA, Lulich JP. Epidemiologic study of risk factors for lower urinary tract diseases in cats. J Am Vet Med Assoc 2001; 218: 1429-1435.
    CrossrefPubMedGoogle Scholar
  • 42 Litster AL, Moss S, Platell J, Trott D. Occult bacterial lower urinary tract infections in cats – urinanalysis and culture findings. Vet Microbiol 2009; 136: 130-134.
    CrossrefPubMedGoogle Scholar
  • 43 Litster A, Thompson M, Moss S, Trott D. Feline bacterial urinary tract infections: An update on an evolving clinical problem. Vet J 2011; 187: 18-22.
    CrossrefPubMedGoogle Scholar
  • 44 Mayer-Roenne B, Goldstein RE, Erb HN. Urinary tract infections in cats with hyperthyroidism, diabetes mellitus and chronic kidney disease. J Feline Med Surg 2007; 09: 124-132.
    CrossrefPubMedGoogle Scholar
  • 45 Mehlhorn AJ, Brown DA. Safety concerns with fluoroquinolones. Ann Pharmacother 2007; 41: 1859-1866.
    CrossrefPubMedGoogle Scholar
  • 46 Meier C. Beitrag zur Bedeutung von bakteriellen Infektionserregern bei Hund und Katze – Eine Auswertung der bakteriologischen Unterschungsbefunde des Instituts für Veterinärbakteriologie. Inaugural-Dissertation; Vetsuisse-Fakultät Universität Zürich: 2004
    Google Scholar
  • 47 Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 2001; 69: 4572-4579.
    CrossrefPubMedGoogle Scholar
  • 48 Osborne CA, Caywood DD, Johnston GR, Polzin DJ, Lulich JP, Kruger JM, Ulrich LK. Feline perineal urethrostomy: a potential cause of feline lower urinary tract disease. Vet Clin North Am Small Anim Pract 1996; 26: 535-49.
    CrossrefPubMedGoogle Scholar
  • 49 Osborne CA, Stevens JB. Urinalysis: A Clinical Guide to Compassionate Patient Care. Veterinary Learning Systems; USA: 1999
    Google Scholar
  • 50 Ramirez CJ, Minch JD, Gay JM, Lahmers SM, Guerra DJ, Haldorson GJ, Schneider T, Mealey KL. Molecular genetic basis for fluoroquinolone-induced retinal degeneration in cats. Pharmacogenet Genomics 2011; 21: 66-75.
    CrossrefPubMedGoogle Scholar
  • 51 Ristic J, Skeldon N. Companion animal practice: Urinalysis in practice – an update. In Practice 2011; 33: 12-19.
    CrossrefPubMedGoogle Scholar
  • 52 Ross DL, Riley CM. Dissociation and complexation of the fluoroquinolone antimicrobials – an update. J Pharm Biomed Anal 1994; 12: 1325-1331.
    CrossrefPubMedGoogle Scholar
  • 53 Scheer M. Concentrations of active ingredient in the serum and in tissues after oral and parenteral administration of Baytril®. Vet Med Res 1987; 02: 104-118.
    PubMedGoogle Scholar
  • 54 Seguin MA, Papich MG, Sigle KJ, Gibson NM, Levy JK. Pharmacokinetics of enrofloxacin in neonatal kittens. Am J Vet Res 2004; 65: 350-356.
    CrossrefPubMedGoogle Scholar
  • 55 Senior DF. Management of urinary tract infections. In: Manual of Canine and Feline Nephrology and Urology. Elliott E, Grauer GF. eds. Quedgeley (UK): BSAVA; 2007: 282-289.
    Google Scholar
  • 56 Spreng M, Delforge J, Thomas V, Boisramé B, Drugeon H. Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. J Vet Pharmacol Ther 1995; 18: 284-289.
    PubMedGoogle Scholar
  • 57 Syme HM. Feline UTIs: Are they common?. Proc. BSAVA Congress; Birmingham: 7-10. April, 2005. 264-266.
    Google Scholar
  • 58 Vallé M. et al. Epidemiosurveillance Study Vétoquinol; Enterobacteriaceae, Ps. aeruginosa, Staphylococcus spp. and Pasteurella multocida isolated from dogs and cats with urinary tract infections. 1994-2007. unpublished.
    PubMedGoogle Scholar
  • 59 Wamsley H, Alleman R. Complete urinalysis. In: Manual of Canine and Feline Nephrology and Urology. Elliott E, Grauer GF. eds. Quedgeley (UK): BSAVA; 2007: 87-116.
    Google Scholar
  • 60 Werckenthin C, Alesik E, Grobbel M, Lübke-Becker A, Schwarz S, Wieler JLH Wallmann. Antimicrobial susceptibility of Pseudomonas aeruginosa from dogs and cats as well as Arcanobacterium pyogenes from cattle and swine as determined in the BfT-GermVet monitoring program 2004–2006. Berl Münch Tierärztl Wschr 2007; 120: 412-422.
    PubMedGoogle Scholar
  • 61 Wiebe V, Hamilton P. Fluoroquinolone-induced retinal degeneration in cats. J Am Vet Med Assoc 2002; 221: 1568-1571.
    CrossrefPubMedGoogle Scholar